Skip to content

Repeated transcranial magnetic stimulation and transcranial direct current stimulation on upper limb dysfunction after stroke

Repeated transcranial magnetic stimulation and transcranial direct current stimulation on upper limb dysfunction after stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073866
Enrollment
Unknown
Registered
2023-07-24
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

rTMS group:The intervention measures were control group therapy plus rTMS adjuvant therapy, rTMS stimulation frequency 5Hz
Stimulation site: primary motor cortex (M1 region) of the affected cerebral hemisphere. Once a day, 6 days a week, for 3 weeks, a total of 18 times. Stimulation parameters: the stimulation frequency w
tDCS group:The intervention measures were control group therapy plus tDCS adjuvant therapy. The stimulation site of tDCS was as follows: the anode was placed in the primary motor cortex (M1 region) of
control group:The intervention measures were routine OT rehabilitation training, including grooming (combing hair), dressing, eating, high disposal, etc. All activities were gradually difficult, once

Sponsors

Yuebei People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Stroke was confirmed by CT or MRI; 2. Course of disease =1 month and =6 months; 3. Age 18-80 years old; 4. Accompanied by upper limb motor dysfunction.

Exclusion criteria

Exclusion criteria: 1. Accompanied by disturbance of consciousness or cognitive dysfunction (MMSE=20 points); 2. Hypertonia, Ashworth grade =? and upper limb muscle strength =2; 3. Patients with severe hypertension (systolic blood pressure >200mmHg, diastolic blood pressure >110mmHg), diabetes with poor blood sugar control or complicated with serious diseases such as dysfunction of liver, kidney, heart and other important organs; 4. Shoulder joint with severe pain (VAS > 7); 5. Severe limited passive motion of shoulder and elbow joints; 6. Patients with refractory or multiple epilepsy; 7. Have a history of serious upper extremity joint diseases; 8. Built-in cardiac pacemaker or other metal medical devices implanted in the body; 9. Unstable fracture, serious osteoporosis; 10. Severe prestroke disability, (modified Rankin Scale, mRS=5); 11. Persons with severe impairment of vision, hearing or understanding; 12. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Upper extremity on the Fugl-Meyer Rating Scale (FMA-UE);Wolf Motor Function Test (WMFT);Upper Limb Movement Study Scale (ARAT);Manual muscle testing (MMT);

Secondary

MeasureTime frame
Modified upper extremity of Ashworth score (MAS-UE);Instrumental Activities of daily Living (IADL);

Countries

China

Contacts

Public ContactQuan Yang

Yuebei People's Hospital

569566514@qq.com+86 136 0021 9290

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026